Loading...
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S‐ICD) has been developed to avert risks associated with transvenous defibrillator leads. The technology is attractive for younger patients, such as those with hypertrophic cardiomyopathy (HCM). However, there are limited data on S...
Na minha lista:
| Udgivet i: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4802466/ https://ncbi.nlm.nih.gov/pubmed/26873684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.002488 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|